Hepatic Steatosis Associated With Exposure to Elvitegravir and Raltegravir

Ditte Marie Kirkegaard-Klitbo; Magda Teresa Thomsen; Marco Gelpi; Flemming Bendtsen; Susanne Dam Nielsen; Thomas Benfield

doi:10.1093/cid/ciab057

Hepatic Steatosis Associated With Exposure to Elvitegravir and Raltegravir

Ditte Marie Kirkegaard-Klitbo, Magda Teresa Thomsen, Marco Gelpi, Flemming Bendtsen, Susanne Dam Nielsen, Thomas Benfield

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

13 Citationer (Scopus)

22 Downloads (Pure)

Abstract

Moderate-to-severe hepatic steatosis in people living with human immunodeficiency virus (HIV) without viral hepatitis or excessive alcohol intake was associated with cumulative exposure to stavudine, elvitegravir, and raltegravir. Prospective trials are required to establish a causal association. Clinical Trials Registration. NCT02382822.

Originalsprog	Engelsk
Tidsskrift	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Vol/bind	73
Udgave nummer	3
Sider (fra-til)	e811-e814
ISSN	1058-4838
DOI	https://doi.org/10.1093/cid/ciab057
Status	Udgivet - 2021

Bibliografisk note

Publisher Copyright:
© Crown copyright 2021.

Adgang til dokumentet

10.1093/cid/ciab057Licens: Andet

Hepatic Steatosis Associated With Exposure to Elvitegravir and RaltegravirForlagets udgivne version, 293 KBLicens: Andet

Citationsformater

Hepatic Steatosis Associated With Exposure to Elvitegravir and Raltegravir. / Kirkegaard-Klitbo, Ditte Marie; Thomsen, Magda Teresa; Gelpi, Marco et al.
I: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Bind 73, Nr. 3, 2021, s. e811-e814.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{ca71f47dcfa845209a74876f641bbcd6,

title = "Hepatic Steatosis Associated With Exposure to Elvitegravir and Raltegravir",

abstract = "Moderate-to-severe hepatic steatosis in people living with human immunodeficiency virus (HIV) without viral hepatitis or excessive alcohol intake was associated with cumulative exposure to stavudine, elvitegravir, and raltegravir. Prospective trials are required to establish a causal association. Clinical Trials Registration. NCT02382822.",

keywords = "ART, HIV, NAFLD",

author = "Kirkegaard-Klitbo, {Ditte Marie} and Thomsen, {Magda Teresa} and Marco Gelpi and Flemming Bendtsen and Nielsen, {Susanne Dam} and Thomas Benfield",

year = "2021",

doi = "10.1093/cid/ciab057",

language = "English",

volume = "73",

pages = "e811--e814",

journal = "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Hepatic Steatosis Associated With Exposure to Elvitegravir and Raltegravir

AU - Kirkegaard-Klitbo, Ditte Marie

AU - Thomsen, Magda Teresa

AU - Gelpi, Marco

AU - Bendtsen, Flemming

AU - Nielsen, Susanne Dam

AU - Benfield, Thomas

PY - 2021

Y1 - 2021

N2 - Moderate-to-severe hepatic steatosis in people living with human immunodeficiency virus (HIV) without viral hepatitis or excessive alcohol intake was associated with cumulative exposure to stavudine, elvitegravir, and raltegravir. Prospective trials are required to establish a causal association. Clinical Trials Registration. NCT02382822.

AB - Moderate-to-severe hepatic steatosis in people living with human immunodeficiency virus (HIV) without viral hepatitis or excessive alcohol intake was associated with cumulative exposure to stavudine, elvitegravir, and raltegravir. Prospective trials are required to establish a causal association. Clinical Trials Registration. NCT02382822.

KW - ART

KW - HIV

KW - NAFLD

U2 - 10.1093/cid/ciab057

DO - 10.1093/cid/ciab057

M3 - Journal article

C2 - 33493297

AN - SCOPUS:85113710760

SN - 1058-4838

VL - 73

SP - e811-e814

JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

IS - 3

ER -